PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVE SUBSTANCES OF THIAZOLIDINEDIONES COMBINED WITH A BIGUANIDE FOR USE IN TYPE 2 DIABETES MELLITUS

摘要

The invention relates to the pharmaceutical industry in general and in particular to the pharmaceutical industry involved in the production of medicaments for controlling type 2 diabetes mellitus. The invention is advantageous over compositions from the prior art in that less of the components are used than when they are consumed separately such as to prevent side or collateral effects, but the same performance or a better performance is achieved nonetheless with said smaller quantities. The inventive composition comprises a pharmaceutical composition containing a substance from the thiazolidinedione group and a biguanide. The composition is characterised in that the aforementioned combination or association consists of a selected substance from the thiazolidinedione group, known as Pioglitazone, and a biguanide known as Metformin, in order to produce a product which has a synergistic effect for the treatment and control of type 2 diabetes mellitus, with fewer side effects.